SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001753926-22-000543
Filing Date
2022-04-18
Accepted
2022-04-18 16:18:01
Documents
2
Group Members
MIKHAIL GUREVICH

Document Format Files

Seq Description Document Type Size
1 SC 13D/A g082974_13d.htm SC 13D/A 50365
2 EXHIBIT 99.1 g082974_ex99-1.htm EX-99.1 33722
  Complete submission text file 0001753926-22-000543.txt   85905
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Subject) CIK: 0001424812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87050 | Film No.: 22832340
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 FRASER LANE WESTPORT CT 06880
Business Address 3 FRASER LANE WESTPORT CT 06880 2032938313
Dominion Capital L.L.C. (Filed by) CIK: 0001532798 (see all company filings)

IRS No.: 452571126 | State of Incorp.: CT | Fiscal Year End: 1231
Type: SC 13D/A